MAIA Biotechnology (MAIA) Other financing activities (2021 - 2026)

MAIA Biotechnology (MAIA) has reported Other financing activities for 5 consecutive years, with $33.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Other financing activities rose 65917.63% year-over-year to $33.0 million in Q1 2026; TTM through Jun 2026 was $39.6 million, a 4172.58% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, down 28.78% from the prior year.
• Other financing activities was $33.0 million for Q1 2026 at MAIA Biotechnology, up from $100000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $33.0 million in Q1 2026 and troughed at $5030.0 in Q2 2024.
• A 4-year average of $4.3 million and a median of $157746.5 in 2024 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities sank 75.0% in 2025 and jumped 65917.63% in 2026, its largest moves.
• Over 4 years, Other financing activities stood at $11.1 million in 2022, then sank by 99.1% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then soared by 32908.81% to $33.0 million in 2026.
• The last three Other financing activities figures came in at $33.0 million (Q1 2026), $100000.0 (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.